Practice Point Communications: Recent Episodes
Practice Point Communications
Practice Point Communications is a medical education company that exclusively partners with academic medical centers to design and develop certified continuing medical education for healthcare providers. Our company offers superior experience and relationships with leading healthcare providers in specialty therapeutic areas with complex educational needs. Our programs are needs-based driven, innovative, well-executed, and provide outcomes validating educational impact. Visit www.PracticePointCME.com to access other educational activities.
What’s New Doc?: CAR T-cells in Multiple Myeloma, highlights key studies and publications from 2024 on the use of these agents in earlier lines of treatment. Dr. Mikhael details how approved and emerging CAR T cell agents in multiple myeloma will impact the treatment landscape and how to better integrate these agents to enable improved outcomes among patients.
Launch Date: December 19, 2024
Release Date: December 19, 2024
Expiration Date: November 30, 2025
FACULTY
Joseph Mikhael, MD, MEd, FRCPC, FACP
Professor, Applied Cancer Research and Drug Discovery, Translational Genomics Research Institute (TGen), City of Hope Cancer Center
Chief Medical Officer, International Myeloma Foundation
Consultant Hematologist and Director, Myeloma Research, Phase 1 Program, HonorHealth Research Institute
Adjunct Professor, College of Health Solutions, Arizona State University
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.
In this Conversations in IFN-y podcast episode, emerging data from the 2024 ACR meeting is discussed, highlighting advancements in understanding genetic drivers, cytokine dynamics, and biomarkers like IL-18 and CXCL9 for improved diagnosis and monitoring. Expert insights explore new findings on liver and lung pathology in MAS, as well as updates on therapeutic innovations, including JAK inhibitors and emapalumab, and their roles in enhancing patient outcomes. Practical strategies are provided for integrating the latest research and cutting-edge diagnostics into clinical practice.
Launch Date: December 19, 2024
Release Date: December 19, 2024
Expiration Date: November 30, 2025
FACULTY
Pui Lee, MD
Assistant Professor of Pediatrics
Boston Children's Hospital
Alexei Grom, MD
Professor of Pediatrics
Research Director
Division of Rheumatology
Cincinnati Children’s Hospital Medical Center
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.
In Highlights and Hindsight in CLL, Dr. Matthew Davids will describe the most significant ongoing studies and publications in CLL from 2024 and will detail their impact on the treatment continuum. This activity will enable participants to stay updated on the most relevant breakthroughs and improve outcomes among patients.
Launch Date: December 18, 2024
Release Date: December 18, 2024
Expiration Date: November 30, 2025
FACULTY
Matthew Davids, MD, MMSc
Director of Clinical Research, Division of Lymphoma
Dana-Farber Cancer Institue
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.
This podcast Clinical Clip features a leading expert highlighting the latest advances in Acute Myeloid Leukemia(AML) treatments presented at the 66th ASH Annual Meeting and Exposition from December 7-10, 2024, in San Diego, CA.
Launch Date: December 16, 2024
Release Date: December 16, 2024
Expiration Date: November 30, 2025
FACULTY
Naval Daver, MD
Director, Leukemia Research Alliance Program,
Professor of Medicine
Department of Leukemia
MD Anderson Cancer Center
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link prior to listening to this podcast.
Clinical Clips in Hemophilia: Cutting-Edge Advances Presented at ASH 2024, will focus on the most exciting abstracts in hemophilia A and B that would be impactful for improved patient care. Dr. Guy Young will discuss the utility of key new evidence on replacement and non-replacement therapy to overcome current limitations and enable improved outcomes among patients.
Launch Date: December 12, 2024
Release Date: December 12, 2024
Expiration Date: November 30, 2025
FACULTY
Guy Young, MD
Professor of Pediatrics
University of Southern California Keck School of Medicine
Director, Hemostasis and Thrombosis Center
Children’s Hospital Los Angeles
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.
https://www.practicepointcme.com/CMEHome/clinical-clips-in-hemophilia-cutting-edge-advances-presented-at-ash-2024-1
Triple-negative breast cancer (TNBC) accounts for 15-20% of all breast cancers. It affects younger women, women of African descent, and those with BRCA1 mutations. TNBC is highly complex, with distinct subtypes that may respond differently to treatments. Recent advancements include immunotherapies, androgen receptor inhibitors, platinum-based drugs, antibody-drug conjugates, PARP inhibitors, and combination therapies. These podcast episodes address educational gaps in TNBC management, offering interactive cases, discussions on emerging treatments, and strategies to improve patient outcomes.
Launch Date: December 5, 2024
Release Date: December 5, 2024
Expiration Date: November 30, 2025
FACULTY
Aditya Bardia, MD, MPH, FASCO
Associate Professor, Medicine, Harvard Medical School
Attending Physician, Medical Oncology, Massachusetts General Hospital
Dana-Farber/Harvard Cancer Center, Boston, MA
Rita Nanda, MD
Associate Professor of Medicine
Director, Breast Oncology Program
The University of Chicago Medicine Chicago, IL
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.
https://www.practicepointcme.com/CMEHome/talking-tnbc-advancing-treatment-in-triple-negative-breast-cancer-latest-insights-and-clinical-strategies-19
Triple-negative breast cancer (TNBC) accounts for 15-20% of all breast cancers. It affects younger women, women of African descent, and those with BRCA1 mutations. TNBC is highly complex, with distinct subtypes that may respond differently to treatments. Recent advancements include immunotherapies, androgen receptor inhibitors, platinum-based drugs, antibody-drug conjugates, PARP inhibitors, and combination therapies. These podcast episodes address educational gaps in TNBC management, offering interactive cases, discussions on emerging treatments, and strategies to improve patient outcomes.
Launch Date: December 5, 2024
Release Date: December 5, 2024
Expiration Date: November 30, 2025
FACULTY
Aditya Bardia, MD, MPH, FASCO
Associate Professor, Medicine, Harvard Medical School
Attending Physician, Medical Oncology, Massachusetts General Hospital
Dana-Farber/Harvard Cancer Center, Boston, MA
Rita Nanda, MD
Associate Professor of Medicine
Director, Breast Oncology Program
The University of Chicago Medicine Chicago, IL
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.
https://www.practicepointcme.com/CMEHome/talking-tnbc-advancing-treatment-in-triple-negative-breast-cancer-latest-insights-and-clinical-strategies-19
Triple-negative breast cancer (TNBC) accounts for 15-20% of all breast cancers. It affects younger women, women of African descent, and those with BRCA1 mutations. TNBC is highly complex, with distinct subtypes that may respond differently to treatments. Recent advancements include immunotherapies, androgen receptor inhibitors, platinum-based drugs, antibody-drug conjugates, PARP inhibitors, and combination therapies. These podcast episodes address educational gaps in TNBC management, offering interactive cases, discussions on emerging treatments, and strategies to improve patient outcomes.
Launch Date: December 5, 2024
Release Date: December 5, 2024
Expiration Date: November 30, 2025
FACULTY
Aditya Bardia, MD, MPH, FASCO
Associate Professor, Medicine, Harvard Medical School
Attending Physician, Medical Oncology, Massachusetts General Hospital
Dana-Farber/Harvard Cancer Center, Boston, MA
Rita Nanda, MD
Associate Professor of Medicine
Director, Breast Oncology Program
The University of Chicago Medicine Chicago, IL
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.
https://www.practicepointcme.com/CMEHome/talking-tnbc-advancing-treatment-in-triple-negative-breast-cancer-latest-insights-and-clinical-strategies-19
This third podcast episode in the series explores advanced understanding of primary hemophagocytic lymphohistiocytosis (HLH), focusing on its genetic basis, diagnostic innovations, and treatment strategies. The discussion highlights the pathophysiology of HLH as an interferon gamma (IFN-γ) driven disease, emphasizing the role of novel diagnostic tools such as flow cytometry and genetic panels. The panel also examines emerging therapies, including JAK inhibitors and IFN-γ monoclonal antibody (emapalumab), in improving outcomes for both primary and secondary HLH. Practical insights into balancing immunosuppression with efficacy offer guidance for optimizing patient care.
Launch Date: December 2, 2024
Release Date: December 2, 2024
Expiration Date: November 30, 2025
FACULTY
Scott Canna, MD
Assistant Professor of Pediatrics
Childrens Hospital of Philadelphia
Pui Lee, MD
Assistant Professor of Pediatrics
Boston Childrens Hospital
Ashish Kumar, MD, PhD
Professor of Pediatrics
Cincinnati Children’s Hospital Medical Center
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.
https://www.practicepointcme.com/CMEHome/conversations-in-ifn-y-driven-diseases-decoding-the-gamma-signal-1
Several new developments in primary biliary cholangitis (PBC) on available and emerging therapies were presented at AASLD 2024. In these podcasts, Dr. Ashwani K. Singal will discuss the most important breakthroughs in the understanding and treatment of PBC and will provide guidance on their impact.
Launch Date: November 26, 2024
Release Date: November 26, 2024
Expiration Date: October 31, 2025
FACULTY
Ashwani K. Singal, MD, MS, FACG, FAASLD, AGAF
Professor of Medicine, University of Louisville
Transplant Hepatologist and Staff Physician
Traeger Transplant Center and Jewish Hospital
Director Clinical Trials, University of Louisville
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.
https://www.practicepointcme.com/CMEHome/clinical-clips174-from-aasld-2024-key-breakthroughs-in-the-treatment-of-primary-biliary-cholangitis-17
Several new developments in primary biliary cholangitis (PBC) on available and emerging therapies were presented at AASLD 2024. In these podcasts, Dr. Ashwani K. Singal will discuss the most important breakthroughs in the understanding and treatment of PBC and will provide guidance on their impact.
Launch Date: November 26, 2024
Release Date: November 26, 2024
Expiration Date: October 31, 2025
FACULTY
Ashwani K. Singal, MD, MS, FACG, FAASLD, AGAF
Professor of Medicine, University of Louisville
Transplant Hepatologist and Staff Physician
Traeger Transplant Center and Jewish Hospital
Director Clinical Trials, University of Louisville
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.
https://www.practicepointcme.com/CMEHome/clinical-clips174-from-aasld-2024-key-breakthroughs-in-the-treatment-of-primary-biliary-cholangitis-17
Patients with interferon gamma (IFN-γ)-driven diseases such as hemophagocytic lymphohistiocytosis (HLH) and macrophage activation syndrome (MAS) face significant diagnostic and therapeutic challenges, with delays in diagnosis and limited effective treatments often resulting in poor outcomes. Despite advances in understanding the role of IFN-γ in these conditions, there remains an unmet need for more precise diagnostic tools and faster, targeted therapies to manage the hyperinflammatory states that characterize these diseases.
Launch Date: November 25, 2024
Release Date: November 25 2024
Expiration Date: October 31, 2025
FACULTY
Scott Canna, MD
Assistant Professor of Pediatrics
Childrens Hospital of Philadelphia
Pui Lee, MD
Assistant Professor of Pediatrics
Boston Childrens Hospital
Ashish Kumar, MD, PhD
Professor of Pediatrics
Cincinnati Children’s Hospital Medical Center
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.
https://www.practicepointcme.com/CMEHome/conversations-in-ifn-y-driven-diseases-decoding-the-gamma-signal-1
Vitiligo is a relatively common acquired pigmentation disorder. The therapeutic effect of all the treatment modalities varies considerably from individual to individual. As such, treatment must be individualized. Moreover, vitiligo can carry significant psychosocial impact. Healthcare providers play a crucial role in shaping patients' understanding of their condition, approach to treatment, and coping mechanisms. In this podcast series, Dr. Raj Chovatiya, along with his patient, will discuss ways to individualized treatment strategies and improve holistic care of patients with vitiligo.
Launch Date: November 21, 2024
Release Date: November 21, 2024
Expiration Date: October 31, 2025
FACULTY
Raj Chovatiya, MD, PhD, MSCI, FAAD
Clinical Associate Professor
Rosalind Franklin University Chicago Medical School
Founder and Director
Center for Medical Dermatology + Immunology Research
Chicago, IL
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.
https://www.practicepointcme.com/CMEHome/ask-the-expert-emerging-evidence-to-improve-outcomes-in-vitiligo
This podcast features an engaging discussion between Dr. Douglas Dieterich and his patient with long-standing PBC, on the patient’s insights and experiences with her disease and treatment. The activity will enable participants to understand the importance of listening to patient perspectives when designing individualized care pathways to alleviate symptoms and improve quality of life.
Launch Date: November 21, 2024
Release Date: November 21, 2024
Expiration Date: October 31, 2025
FACULTY
Douglas Dieterich, MD
Director, Institute for Liver Medicine at Mount Sinai
Professor of Medicine, Icahn School of Medicine at Mount Sinai
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.
https://www.practicepointcme.com/CMEHome/patient-voices-in-primary-biliary-cholangitis-a-ce-podcast-series-to-recognize-challenges-reduce-disparities-and-improve-outcomes
Despite significant advancements in the management of pulmonary hypertension (PH), several unmet needs remain. Patients continue to face challenges related to symptom control, mental health, and the long-term impacts of both the disease and its treatments. Additionally, there is a critical need for improved global access to care, multidimensional support, and advocacy. In this podcast episode, Dr. Jean Elwing and Dr. Oksana Shlobin discuss these gaps by focusing on the latest updates from the 7th World Symposium on Pulmonary Hypertension (WSPH), offering insights into the latest clinical classifications, risk stratifications, and treatment strategies.
This podcast aims to enhance clinical practice by presenting key research findings, new treatment algorithms, and the implications of emerging therapies. The discussion will include advances in multimodality imaging, genetics, and right ventricular function, highlighting how these innovations improve PH diagnosis and patient management. Through an expert-led presentation and interactive Q&A session, participants will gain a comprehensive understanding of how these developments will shape future research and personalized care for PH patients.
Launch Date: November 19, 2024
Release Date: November 19, 2024
Expiration Date: October 31, 2025
FACULTY
Jean Elwing, MD
Professor of Medicine
Director, Pulmonary Hypertension Program
University of Cincinnati
Oksana Shlobin, MD
Medical Director, Pulmonary Hypertension Program
Director of Education and Outreach, Advanced Lung Disease Program
Inova Fairfax Hospital
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.
https://www.practicepointcme.com/CMEHome/talking-pah-updates-from-the-7th-world-symposium-on-pulmonary-hypertension-1
Patients with interferon gamma (IFN-γ)-driven diseases such as hemophagocytic lymphohistiocytosis (HLH) and macrophage activation syndrome (MAS) face significant diagnostic and therapeutic challenges, with delays in diagnosis and limited effective treatments often resulting in poor outcomes. Despite advances in understanding the role of IFN-γ in these conditions, there remains an unmet need for more precise diagnostic tools and faster, targeted therapies to manage the hyperinflammatory states that characterize these diseases.
Launch Date: November 18, 2024
Release Date: November 18, 2024
Expiration Date: October 31, 2025
FACULTY
Scott Canna, MD
Assistant Professor of Pediatrics
Childrens Hospital of Philadelphia
Pui Lee, MD
Assistant Professor of Pediatrics
Boston Childrens Hospital
Ashish Kumar, MD, PhD
Professor of Pediatrics
Cincinnati Children’s Hospital Medical Center
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.
https://www.practicepointcme.com/CMEHome/conversations-in-ifn-y-driven-diseases-decoding-the-gamma-signal-1
Advances in HIV research often unfold rapidly. In order to deliver state-of-the-art care, healthcare providers who manage this patient population must stay abreast of data emerging from the major conferences.
These educational podcasts will spotlight the latest advances in the treatment and prevention of HIV and related comorbidities with a series of ‘what you need to know’ podcast episodes from data presented during HIV Drug Therapy, Glasgow 2024.
Launch Date: November 18, 2024
Release Date: November 18, 2024
Expiration Date: October 31, 2025
FACULTY
Anton Pozniak, MD, FRCP
Consultant Physician
Chelsea and Westminster Hospital London UK
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.
https://www.practicepointcme.com/CMEHome/clinical-clips174-spotlighting-hot-topics-in-hiv-independent-coverage-from-hiv-drug-therapy-glasgow-2024-1
Advances in HIV research often unfold rapidly. In order to deliver state-of-the-art care, healthcare providers who manage this patient population must stay abreast of data emerging from the major conferences.
These educational podcasts will spotlight the latest advances in the treatment and prevention of HIV and related comorbidities with a series of ‘what you need to know’ podcast episodes from data presented during HIV Drug Therapy, Glasgow 2024.
Launch Date: November 18, 2024
Release Date: November 18, 2024
Expiration Date: October 31, 2025
FACULTY
Anton Pozniak, MD, FRCP
Consultant Physician
Chelsea and Westminster Hospital London UK
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.
https://www.practicepointcme.com/CMEHome/clinical-clips174-spotlighting-hot-topics-in-hiv-independent-coverage-from-hiv-drug-therapy-glasgow-2024-1
Vitiligo is a relatively common acquired pigmentation disorder. The therapeutic effect of all the treatment modalities varies considerably from individual to individual. As such, treatment must be individualized. Moreover, vitiligo can carry significant psychosocial impact. Healthcare providers play a crucial role in shaping patients' understanding of their condition, approach to treatment, and coping mechanisms. In this podcast series, Dr. Raj Chovatiya, along with his patient, will discuss ways to individualized treatment strategies and improve holistic care of patients with vitiligo.
Launch Date: November 14, 2024
Release Date: November 14, 2024
Expiration Date: October 31, 2025
FACULTY
Raj Chovatiya, MD, PhD, MSCI, FAAD
Clinical Associate Professor
Rosalind Franklin University Chicago Medical School
Founder and Director
Center for Medical Dermatology + Immunology Research
Chicago, IL
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.
https://www.practicepointcme.com/CMEHome/ask-the-expert-emerging-evidence-to-improve-outcomes-in-vitiligo
Patients with plexiform neurofibromas (PN) associated with neurofibromatosis type 1 (NF1) experience considerable morbidity, a poor quality of life, and increased mortality. Research efforts have led to earlier diagnosis, new monitoring approaches, emerging treatment options, and considerations for surgical intervention. To this end, it is critical that pediatric oncologists as well as other members of the multidisciplinary team neurologists caring for patients with NF1-PN are up to date on recent advances. In this podcast lecture library, Dr. Armstrong uses a case-based discussion to address the heterogeneity and complexity of this condition as well as considerations for the use of emerging therapies when making individualized management decisions among diverse patients.
Launch Date: October 31, 2024
Release Date: October 31, 2024
Expiration Date: September 30, 2025
FACULTY
Amy Armstrong, MD
Assistant Professor of Pediatrics
Division of Hematology/Oncology
Neurofibromatosis (NF) Center
Washington University School of Medicine
St. Louis, Missouri
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.
https://www.practicepointcme.com/CMEHome/neurofibromatosis-type-1-related-plexiform-neurofibromas-improving-diagnosis-and-monitoring-while-integrating-ongoing-updates-in-the-treatment-continuum-1
This podcast features an engaging discussion between Dr. David Victor and his patient, with long-standing PBC, on the patient’s insights and experiences with her disease and treatment. The activity will enable participants to understand the importance of listening to patient perspectives when designing individualized care pathways to alleviate symptoms and improve quality of life.
Launch Date: October 24, 2024
Release Date: October 24, 2024
Expiration Date: September 30, 2025
FACULTY
David W. Victor III, MD
Associate Professor of Clinical Medicine
Houston Methodist Research Institute
Associate Professor of Clinical Medicine
Weill Cornell Medicine
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.
https://www.practicepointcme.com/CMEHome/patient-voices-in-primary-biliary-cholangitis-a-ce-podcast-series-to-recognize-challenges-reduce-disparities-and-improve-outcomes
These educational podcasts will spotlight the latest advances in the treatment and prevention of HIV and related comorbidities with a series of ‘what you need to know’ podcast episodes from data presented during IDWeek 2024.
Launch Date: October 23, 2024
Release Date: October 23, 2024
Expiration Date: September 30, 2025
FACULTY
Joseph Eron, MD
Professor of Medicine
University of North Carolina at Chapel Hill
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.
https://www.practicepointcme.com/CMEHome/clinical-clips174-spotlighting-hot-topics-in-hiv-independent-coverage-from-idweek-2024-1
These educational podcasts will spotlight the latest advances in the treatment and prevention of HIV and related comorbidities with a series of ‘what you need to know’ podcast episodes from data presented during IDWeek 2024.
Launch Date: October 23, 2024
Release Date: October 23, 2024
Expiration Date: September 30, 2025
FACULTY
Joseph Eron, MD
Professor of Medicine
University of North Carolina at Chapel Hill
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.
https://www.practicepointcme.com/CMEHome/clinical-clips174-spotlighting-hot-topics-in-hiv-independent-coverage-from-idweek-2024-1
Pulmonary hypertension among patients with interstitial lung diseases (PH-ILD) is currently under-recognized and is associated with increased morbidity, mortality, and healthcare burden. Individualized treatment approaches need to be incorporated in the continuum of care to improve early detection, accurate diagnosis, and improved patient outcomes. In this podcast series, Drs. Jean Elwing, Steven Nathan, and Ioana Preston inform and guide on recent insights to screen for, detect, and accurately diagnose PH-ILD. This on-demand audio presentation uses didactic, case-based, and conversational formats to provide practical guidance and increase familiarity with the latest best-practice approaches for treatment and management of PH-ILD, to ultimately improve the quality of life of patients.
Launch Date: October 14, 2024
Release Date: October 7, 2024
Expiration Date: September 30, 2025
FACULTY
Steven Nathan, MD
Medical Director, Advanced Lung Disease and Transplant Program
Inova Fairfax Hospital
Jean Elwing, MD
Professor of Medicine
Director, Pulmonary Hypertension Program
University of Cincinnati
Ioana Preston, MD
Associate Professor of Medicine
Tufts University School of Medicine
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.
https://www.practicepointcme.com/CMEHome/expert-guided-strategies-to-improve-recognition-diagnosis-and-treatment-of-ph-associated-with-ild-1
Pulmonary hypertension among patients with interstitial lung diseases (PH-ILD) is currently under-recognized and is associated with increased morbidity, mortality, and healthcare burden. Individualized treatment approaches need to be incorporated in the continuum of care to improve early detection, accurate diagnosis, and improved patient outcomes. In this podcast series, Drs. Jean Elwing, Steven Nathan, and Ioana Preston inform and guide on recent insights to screen for, detect, and accurately diagnose PH-ILD. This on-demand audio presentation uses didactic, case-based, and conversational formats to provide practical guidance and increase familiarity with the latest best-practice approaches for treatment and management of PH-ILD, to ultimately improve the quality of life of patients.
Launch Date: October 14, 2024
Release Date: October 7, 2024
Expiration Date: September 30, 2025
FACULTY
Steven Nathan, MD
Medical Director, Advanced Lung Disease and Transplant Program
Inova Fairfax Hospital
Jean Elwing, MD
Professor of Medicine
Director, Pulmonary Hypertension Program
University of Cincinnati
Ioana Preston, MD
Associate Professor of Medicine
Tufts University School of Medicine
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.
https://www.practicepointcme.com/CMEHome/expert-guided-strategies-to-improve-recognition-diagnosis-and-treatment-of-ph-associated-with-ild-1
Pulmonary hypertension among patients with interstitial lung diseases (PH-ILD) is currently under-recognized and is associated with increased morbidity, mortality, and healthcare burden. Individualized treatment approaches need to be incorporated in the continuum of care to improve early detection, accurate diagnosis, and improved patient outcomes. In this podcast series, Drs. Jean Elwing, Steven Nathan, and Ioana Preston inform and guide on recent insights to screen for, detect, and accurately diagnose PH-ILD. This on-demand audio presentation uses didactic, case-based, and conversational formats to provide practical guidance and increase familiarity with the latest best-practice approaches for treatment and management of PH-ILD, to ultimately improve the quality of life of patients.
Launch Date: October 14, 2024
Release Date: October 7, 2024
Expiration Date: September 30, 2025
FACULTY
Steven Nathan, MD
Medical Director, Advanced Lung Disease and Transplant Program
Inova Fairfax Hospital
Jean Elwing, MD
Professor of Medicine
Director, Pulmonary Hypertension Program
University of Cincinnati
Ioana Preston, MD
Associate Professor of Medicine
Tufts University School of Medicine
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.
https://www.practicepointcme.com/CMEHome/expert-guided-strategies-to-improve-recognition-diagnosis-and-treatment-of-ph-associated-with-ild-1
These educational podcasts will spotlight important research into the basic science, diagnosis, treatment, and medical management of patients with PAH based on data presented at the American College of Chest Physicians (CHEST) Annual Meeting in Boston, MA October 6-9, 2024.
Launch Date: October 10, 2024
Release Date: October 10, 2024
Expiration Date: September 30, 2025
FACULTY
Ioana Preston, MD
Associate Professor of Medicine
Tufts University School of Medicine
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.
https://www.practicepointcme.com/CMEHome/independent-conference-coverage-from-the-american-college-of-chest-physicians-chest-annual-meeting-2024-1
These educational podcasts will spotlight important research into the basic science, diagnosis, treatment, and medical management of patients with PAH based on data presented at the American College of Chest Physicians (CHEST) Annual Meeting in Boston, MA October 6-9, 2024.
Launch Date: October 10 2024
Release Date: October 10, 2024
Expiration Date: September 30, 2025
FACULTY
Ioana Preston, MD
Associate Professor of Medicine
Tufts University School of Medicine
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.
https://www.practicepointcme.com/CMEHome/independent-conference-coverage-from-the-american-college-of-chest-physicians-chest-annual-meeting-2024-1
Bispecific antibodies represent a much-needed option for diverse patients with relapsed/refractory multiple myeloma (RRMM). This podcast activity will highlight key clinical trial evidence leading to approval of bispecific antibodies and will provide guidance on safely incorporating these agents into RRMM treatment paradigms. Clinical case scenarios will also be discussed to optimize and sequence bispecific antibodies to enable improved outcomes among distinct patient subsets.
Launch Date: October 3 2024
Release Date: October 3, 2024
Expiration Date: September 30, 2025
FACULTY
Joseph Mikhael, MD, MEd, FRCPC, FACP
Professor, Applied Cancer Research and Drug Discovery, Translational Genomics Research Institute (TGen), City of Hope Cancer Center
Chief Medical Officer, International Myeloma Foundation
Consultant Hematologist and Director, Myeloma Research, Phase 1 Program, HonorHealth Research Institute
Adjunct Professor, College of Health Solutions, Arizona State University
Caitlin Costello, MD
Clinical Professor of Medicine
Director, Multiple Myeloma Program
Division of Blood and Marrow Transplantation
Moores Cancer Center
UC San Diego
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.
https://www.practicepointcme.com/CMEHome/relapsedrefractory-multiple-myeloma-podcast-series-clinical-viewpoints-to-individualize-bispecific-antibody-therapy
Bispecific antibodies represent a much-needed option for diverse patients with relapsed/refractory multiple myeloma (RRMM). This podcast activity will highlight key clinical trial evidence leading to approval of bispecific antibodies and will provide guidance on safely incorporating these agents into RRMM treatment paradigms. Clinical case scenarios will also be discussed to optimize and sequence bispecific antibodies to enable improved outcomes among distinct patient subsets.
Launch Date: October 1, 2024
Release Date: October 1, 2024
Expiration Date: September 30, 2025
FACULTY
Joseph Mikhael, MD, MEd, FRCPC, FACP
Professor, Applied Cancer Research and Drug Discovery, Translational Genomics Research Institute (TGen), City of Hope Cancer Center
Chief Medical Officer, International Myeloma Foundation
Consultant Hematologist and Director, Myeloma Research, Phase 1 Program, HonorHealth Research Institute
Adjunct Professor, College of Health Solutions, Arizona State University
Caitlin Costello, MD
Clinical Professor of Medicine
Director, Multiple Myeloma Program
Division of Blood and Marrow Transplantation
Moores Cancer Center
UC San Diego
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.
https://www.practicepointcme.com/CMEHome/relapsedrefractory-multiple-myeloma-podcast-series-clinical-viewpoints-to-individualize-bispecific-antibody-therapy
Clinicians often encounter patients having complex clinical scenarios when managing PH where diverse and dynamic diagnostic and therapeutic issues interact. In this podcast episode, Dr. De Marco and Dr. Oudiz discuss complex clinical case scenarios to improve knowledge of the diagnosis and management of hypertension and its application in practice.
Launch Date: September 4, 2024
Release Date: September 4, 2024
Expiration Date: August 31, 2025
FACULTY
Ronald J. Oudiz, MD, FACP, FACC, FCCP
Chief, Division of Cardiology
Professor of Medicine
The David Geffen School of Medicine at UCLA
Director, Pulmonary Hypertension Clinic
Harbor-UCLA Medical Center
Teresa De Marco, MD
Professor of Medicine; R.H. and Jane G. Logan Endowed Chair in Cardiology
University of California, San Francisco
Medical Director Heart Transplantation
Burlingame, California
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.
https://www.practicepointcme.com/CMEHome/talking-pah-navigating-clinical-challenges-through-case-studies-of-complex-scenarios-12
This podcast features an engaging discussion between Dr. Douglas Dieterich and his patient, a 54-year-old woman with long-standing PBC, on the patient’s insights and experiences with her disease and treatment. The activity will enable participants to understand the importance of listening to patient perspectives when designing individualized care pathways to alleviate symptoms and improve quality of life.
Launch Date: August 21, 2024
Release Date: August 21, 2024
Expiration Date: July 31, 2025
FACULTY
Douglas Dieterich, MD
Director, Institute for Liver Medicine at Mount Sinai
Professor of Medicine, Icahn School of Medicine at Mount Sinai
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.
https://www.practicepointcme.com/CMEHome/patient-voices-in-primary-biliary-cholangitis-a-ce-podcast-series-to-recognize-challenges-reduce-disparities-and-improve-outcomes
Estimated to impact at least 125 million people worldwide, the burden of living with psoriasis runs more than skin deep. From the physical impact and comorbidities to the emotional toll that may plague everyday life, many patients still struggle with inadequate disease control, often going untreated or undertreated, despite the myriad treatment options available. There is a significant need for new psoriasis treatment options, and this interactive program is designed to provide expert interpretation of new and emerging data on the treatment of psoriasis, with multidisciplinary expert perspectives on how new agents can impact clinical practice. This podcast will discuss how to help clinicians select the most appropriate treatment as well as address the significant health burdens and comorbidities experienced by many patients with psoriasis.
Launch Date: August 15, 2024
Release Date: August 15, 2024
Expiration Date: July 31, 2025
FACULTY
Bruce Strober, MD, PhD
Clinical Professor
Yale University and Central Connecticut University
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.
https://www.practicepointcme.com/CMEHome/optimizing-outcomes-in-psoriasis-exploring-the-impact-of-rapid-diagnosis-and-emerging-therapeutic-agents
Advances in HIV research often unfold rapidly. In order to deliver state-of-the-art care, healthcare providers who manage this patient population must stay abreast of data emerging from the major conferences.
These educational podcasts will spotlight the latest advances in the treatment and prevention of HIV and related comorbidities with a series of ‘what you need to know’ videos from data presented during the 25th International AIDS Conference.
Launch Date: August 1, 2024
Release Date: August 1, 2024
Expiration Date: July 31, 2025
FACULTY
Paul Sax, MD
Clinical Director
Division of Infectious Diseases
Brigham and Women’s Hospital
Professor of Medicine
Harvard Medical School
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.
https://www.practicepointcme.com/CMEHome/clinical-clips174-spotlighting-hot-topics-in-hiv-independent-coverage-from-the-25th-international-aids-conference-aids-2024-1
Advances in HIV research often unfold rapidly. In order to deliver state-of-the-art care, healthcare providers who manage this patient population must stay abreast of data emerging from the major conferences.
These educational podcasts will spotlight the latest advances in the treatment and prevention of HIV and related comorbidities with a series of ‘what you need to know’ videos from data presented during the 25th International AIDS Conference.
Launch Date: August 1, 2024
Release Date: August 1, 2024
Expiration Date: July 31, 2025
FACULTY
Paul Sax, MD
Clinical Director
Division of Infectious Diseases
Brigham and Women’s Hospital
Professor of Medicine
Harvard Medical School
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.
https://www.practicepointcme.com/CMEHome/clinical-clips174-spotlighting-hot-topics-in-hiv-independent-coverage-from-the-25th-international-aids-conference-aids-2024-1
Advances in HIV research often unfold rapidly. In order to deliver state-of-the-art care, healthcare providers who manage this patient population must stay abreast of data emerging from the major conferences.
These educational podcasts will spotlight the latest advances in the treatment and prevention of HIV and related comorbidities with a series of ‘what you need to know’ videos from data presented during the 25th International AIDS Conference.
Launch Date: August 1, 2024
Release Date: August 1, 2024
Expiration Date: July 31, 2025
FACULTY
Paul Sax, MD
Clinical Director
Division of Infectious Diseases
Brigham and Women’s Hospital
Professor of Medicine
Harvard Medical School
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.
https://www.practicepointcme.com/CMEHome/clinical-clips174-spotlighting-hot-topics-in-hiv-independent-coverage-from-the-25th-international-aids-conference-aids-2024-1
Advances in HIV research often unfold rapidly. In order to deliver state-of-the-art care, healthcare providers who manage this patient population must stay abreast of data emerging from the major conferences.
These educational podcasts will spotlight the latest advances in the treatment and prevention of HIV and related comorbidities with a series of ‘what you need to know’ videos from data presented during the 25th International AIDS Conference.
Launch Date: August 1, 2024
Release Date: August 1, 2024
Expiration Date: July 31, 2025
FACULTY
Paul Sax, MD
Clinical Director
Division of Infectious Diseases
Brigham and Women’s Hospital
Professor of Medicine
Harvard Medical School
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.
https://www.practicepointcme.com/CMEHome/clinical-clips174-spotlighting-hot-topics-in-hiv-independent-coverage-from-the-25th-international-aids-conference-aids-2024-1
Hereditary Angioedema (HAE) poses significant challenges for patients and healthcare providers alike, with recurrent attacks impacting quality of life and posing risks of severe complications. While advancements in treatment options have improved acute management, there remains unmet needs in the realm of long-term prophylaxis. In this podcast series, Dr. Timothy Craig and Dr. Marc Riedl will delve into the complexities of HAE management, focusing specifically on emerging solutions for long-term prophylaxis. Through their discussions, they provide insights into the challenges faced by patients with HAE, the limitations of current prophylactic options, and the potential avenues for innovation and improvement in the long-term management of HAE.
Launch Date: July 26, 2024
Release Date: July 26, 2024
Expiration Date: June 30, 2025
FACULTY
Timothy Craig, DO, FAAAAI, FACP, FACAAI, FACOI
Tenured Professor of Medicine
Pediatrics and Distinguished Educator
Pennsylvania State University
Marc Riedl, MD, MS
Professor of Medicine
University of California, San Diego
Clinical Director - US HAEA Angioedema Center
University of California, San Diego
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.
https://www.practicepointcme.com/CMEHome/patient-centered-approaches-to-long-term-prophylaxis-in-hae-1
Hereditary Angioedema (HAE) poses significant challenges for patients and healthcare providers alike, with recurrent attacks impacting quality of life and posing risks of severe complications. While advancements in treatment options have improved acute management, there remains unmet needs in the realm of long-term prophylaxis. In this podcast series, Dr. Timothy Craig and Dr. Marc Riedl will delve into the complexities of HAE management, focusing specifically on emerging solutions for long-term prophylaxis. Through their discussions, they provide insights into the challenges faced by patients with HAE, the limitations of current prophylactic options, and the potential avenues for innovation and improvement in the long-term management of HAE.
Launch Date: July 26, 2024
Release Date: July 26, 2024
Expiration Date: June 30, 2025
FACULTY
Timothy Craig, DO, FAAAAI, FACP, FACAAI, FACOI
Tenured Professor of Medicine
Pediatrics and Distinguished Educator
Pennsylvania State University
Marc Riedl, MD, MS
Professor of Medicine
University of California, San Diego
Clinical Director - US HAEA Angioedema Center
University of California, San Diego
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.
https://www.practicepointcme.com/CMEHome/patient-centered-approaches-to-long-term-prophylaxis-in-hae-1
Hereditary Angioedema (HAE) poses significant challenges for patients and healthcare providers alike, with recurrent attacks impacting quality of life and posing risks of severe complications. While advancements in treatment options have improved acute management, there remains unmet needs in the realm of long-term prophylaxis. In this podcast series, Dr. Timothy Craig and Dr. Marc Riedl will delve into the complexities of HAE management, focusing specifically on emerging solutions for long-term prophylaxis. Through their discussions, they provide insights into the challenges faced by patients with HAE, the limitations of current prophylactic options, and the potential avenues for innovation and improvement in the long-term management of HAE.
Launch Date: July 26, 2024
Release Date: July 26, 2024
Expiration Date: June 30, 2025
FACULTY
Timothy Craig, DO, FAAAAI, FACP, FACAAI, FACOI
Tenured Professor of Medicine
Pediatrics and Distinguished Educator
Pennsylvania State University
Marc Riedl, MD, MS
Professor of Medicine
University of California, San Diego
Clinical Director - US HAEA Angioedema Center
University of California, San Diego
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.
https://www.practicepointcme.com/CMEHome/patient-centered-approaches-to-long-term-prophylaxis-in-hae-1
In this podcast series, Dr. Orlowski, Dr. Raje, and Dr. Voorhees inform and guide participants on latest developments from clinical trials on quadruplet and triplet regimens, based on updates from the European Hematology Association (EHA) 2024 meeting. Using clinical case scenarios, they’ll clarify clinical endpoints and outcomes to enable safe and effective frontline regimen choices among diverse patients with newly diagnosed multiple myeloma (NDMM) who have distinct needs. Listen to the available episodes as experts lay the foundation for optimal first-line, maintenance, transplantation, and subsequent therapy choice based on the risk profile of patients, to ultimately improve outcomes in multiple myeloma (MM).
Launch Date: July 19, 2024
Release Date: June 26, 2024
Expiration Date: June 30, 2025
FACULTY
Robert Orlowski, MD, PhD
Professor of Medicine
Director, Section of Myeloma
The University of Texas, MD Anderson Cancer Center
Noopur Raje, MD
Director, Center for Multiple Myeloma
Massachusetts General Hospital
Peter Voorhees, MD
Chief, Plasma Cell Disorders Division
Atrium Health / Levine Cancer Institute
Clinical Professor of Medicine
Wake Forest University School of Medicine
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.
https://www.practicepointcme.com/CMEHome/integrating-quadruplet-regimens-in-newly-diagnosed-multiple-myeloma-patient-focused-strategies-to-improve-outcomes-43
In this podcast series, Dr. Orlowski, Dr. Raje, and Dr. Voorhees inform and guide participants on latest developments from clinical trials on quadruplet and triplet regimens, based on updates from the European Hematology Association (EHA) 2024 meeting. Using clinical case scenarios, they’ll clarify clinical endpoints and outcomes to enable safe and effective frontline regimen choices among diverse patients with newly diagnosed multiple myeloma (NDMM) who have distinct needs. Listen to the available episodes as experts lay the foundation for optimal first-line, maintenance, transplantation, and subsequent therapy choice based on the risk profile of patients, to ultimately improve outcomes in multiple myeloma (MM).
Launch Date: July 19, 2024
Release Date: June 26, 2024
Expiration Date: June 30, 2025
FACULTY
Robert Orlowski, MD, PhD
Professor of Medicine
Director, Section of Myeloma
The University of Texas, MD Anderson Cancer Center
Noopur Raje, MD
Director, Center for Multiple Myeloma
Massachusetts General Hospital
Peter Voorhees, MD
Chief, Plasma Cell Disorders Division
Atrium Health / Levine Cancer Institute
Clinical Professor of Medicine
Wake Forest University School of Medicine
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.
https://www.practicepointcme.com/CMEHome/integrating-quadruplet-regimens-in-newly-diagnosed-multiple-myeloma-patient-focused-strategies-to-improve-outcomes-43
In this podcast series, Dr. Orlowski, Dr. Raje, and Dr. Voorhees inform and guide participants on latest developments from clinical trials on quadruplet and triplet regimens, based on updates from the European Hematology Association (EHA) 2024 meeting. Using clinical case scenarios, they’ll clarify clinical endpoints and outcomes to enable safe and effective frontline regimen choices among diverse patients with newly diagnosed multiple myeloma (NDMM) who have distinct needs. Listen to the available episodes as experts lay the foundation for optimal first-line, maintenance, transplantation, and subsequent therapy choice based on the risk profile of patients, to ultimately improve outcomes in multiple myeloma (MM).
Launch Date: July 19, 2024
Release Date: June 26, 2024
Expiration Date: June 30, 2025
FACULTY
Robert Orlowski, MD, PhD
Professor of Medicine
Director, Section of Myeloma
The University of Texas, MD Anderson Cancer Center
Noopur Raje, MD
Director, Center for Multiple Myeloma
Massachusetts General Hospital
Peter Voorhees, MD
Chief, Plasma Cell Disorders Division
Atrium Health / Levine Cancer Institute
Clinical Professor of Medicine
Wake Forest University School of Medicine
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.
https://www.practicepointcme.com/CMEHome/integrating-quadruplet-regimens-in-newly-diagnosed-multiple-myeloma-patient-focused-strategies-to-improve-outcomes-43
This podcast will provide expert interpretation of new and emerging data on the pathophysiology, diagnosis and treatment of MF presented at the 2024 European Hematology Association (EHA 2024) Hybrid Congress, June 13-16, Madrid, Spain.
This is an accredited continuing education podcast as downloadable audio file (MP3) available for AMA/ABS/ANCC credit.
Launch Date: June 17, 2024
Release Date: June 17, 2024
Expiration Date: May 31, 2025
Faculty Bio
John Mascarenhas, MD
Professor of Medicine
Icahn School of Medicine at Mount Sinai
Director of the Center of Excellence
for Blood Cancers and Myeloid Disorders
New York, New York
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.
https://www.practicepointcme.com/CMEHome/podcast-from-eha-2024-advancements-in-myelofibrosis-from-pathophysiology-to-personalized-treatment-strategies
This podcast will ensure that HCPs who treat / manage patients with NDMM are up-to-date on key data presented at the 2024 European Hematology Association Annual Congress (EHA 2024), June 13-16, 2024 in Madrid, Spain and will aid learners in safely applying recent evidence into practice.
This is an accredited continuing education podcast as downloadable audio file (MP3) available for AMA/ABS/ANCC/ACPE credit.
Launch Date: June 17, 2024
Release Date: June 17, 2024
Expiration Date: May 31, 2025
Faculty Bio
Peter Voorhees, MD
Clinical Professor, Hematology and Oncology
Wake Forest University School of Medicine
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.
https://www.practicepointcme.com/CMEHome/podcasts-in-advanced-newly-diagnosed-multiple-myeloma-updates-from-eha-2024
Immune thrombocytopenic purpura (ITP) is an acquired autoimmune disease characterized by a low platelet count, purpura, and hemorrhagic episodes caused by antiplatelet autoantibodies. Diagnosis is typically made by excluding the known causes of thrombocytopenia. Recent advancements in pediatric ITP treatment show promise for personalized medicine and better outcomes. This podcast will provide expert interpretation of new and emerging data on the pathophysiology, diagnosis and treatment of pediatric ITP presented at the EHA 2024 Hybrid Congress, June 13-16, Madrid, Spain.
Launch Date: June 17, 2024
Release Date: June 17, 2024
Expiration Date: May 31, 2025
FACULTY
Cindy Neunert, MD
Associate Professor of Pediatrics
Columbia University Irving Medical Center
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.
https://www.practicepointcme.com/CMEHome/podcasts-in-pediatric-itp-advancements-in-pediatric-itp-management-insights-from-eha-2024
Several new developments in primary biliary cholangitis (PBC) on available and emerging therapies will be presented at the annual European Association for the Study of the Liver (EASL) 2024 Congress in Milan, Italy. In this podcast series, Dr. Kris Kowdley will discuss the most important breakthroughs in the understanding and treatment of PBC presented at the EASL Congress 2024 and will provide guidance on their impact.
This is an accredited continuing education podcast as downloadable audio file (MP3) available for AMA/ABS/ANCC/ACPE credit.
Launch Date: June 11, 2024
Release Date: June 11, 2024
Expiration Date: May 31, 2025
Faculty Bio
Kris V. Kowdley, MD, AGAF, FAASLD, FACG, FACP
Director, Liver Institute Northwest
Professor, Elson S. Floyd College of Medicine
Washington State University
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.
https://www.practicepointcme.com/CMEHome/podcast-from-easl-congress-2024-key-breakthroughs-in-the-treatment-of-primary-biliary-cholangitis
Several new developments in primary biliary cholangitis (PBC) on available and emerging therapies will be presented at the annual European Association for the Study of the Liver (EASL) 2024 Congress in Milan, Italy. In this podcast series, Dr. Kris Kowdley will discuss the most important breakthroughs in the understanding and treatment of PBC presented at the EASL Congress 2024 and will provide guidance on their impact.
This is an accredited continuing education podcast as downloadable audio file (MP3) available for AMA/ABS/ANCC/ACPE credit.
Launch Date: June 11, 2024
Release Date: June 11, 2024
Expiration Date: May 31, 2025
Faculty Bio
Kris V. Kowdley, MD, AGAF, FAASLD, FACG, FACP
Director, Liver Institute Northwest
Professor, Elson S. Floyd College of Medicine
Washington State University
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.
https://www.practicepointcme.com/CMEHome/podcast-from-easl-congress-2024-key-breakthroughs-in-the-treatment-of-primary-biliary-cholangitis
This is an accredited continuing education podcast as a downloadable audio file (MP3). This certified AMA/ABS/ANCC podcast ensures clinicians are up-to-date on key data for NSCLC harboring EGFR mutations presented at the 2024 ASCO Annual Meeting in Chicago, IL May 31 – June 4, 2024 and aids learners in safely applying recent evidence into practice.
Launch Date: June 5, 2024
Release Date: June 5, 2024
Expiration Date: May 31, 2025
FACULTY BIO
Stephen Liu, MD
Associate Professor of Medicine
Director of Thoracic Oncology
Director of Developmental Therapeutics
Lombardi Comprehensive Cancer Center
Georgetown University
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.
https://www.practicepointcme.com/CMEHome/podcasts-in-nsclc-harboring-egfr-mutations-cutting-edge-reports-from-asco-2024
This is an accredited continuing education series of three (3) podcasts as downloadable audio files (MP3). These certified AMA/ABS/ANCC podcasts will clarify the rationale and best-practice approaches for HRRm testing to guide therapeutic strategies in metastatic prostate cancer. Clinical case scenarios are used to enhance the learning experience and provide practical considerations to achieve improved outcomes among patients.
Launch Date: May 30, 2024
Release Date: May 30, 2024
Expiration Date: April 30, 2025
FACULTY BIO
Andrew Armstrong, MD, ScM, FACP
Professor of Medicine, Surgery, Pharmacology and Cancer Biology
Duke University
Tanya Dorff, MD
Professor of Medicine
City of Hope
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.
https://www.practicepointcme.com/CMEHome/talking-prostate-cancer-homologous-recombination-repair-gene-mutation-testing-in-metastatic-prostate-cancer-8
This is an accredited continuing education series of three (3) podcasts as downloadable audio files (MP3). These certified AMA/ABS/ANCC podcasts will clarify the rationale and best-practice approaches for HRRm testing to guide therapeutic strategies in metastatic prostate cancer. Clinical case scenarios are used to enhance the learning experience and provide practical considerations to achieve improved outcomes among patients.
Launch Date: May 30, 2024
Release Date: May 30, 2024
Expiration Date: April 30, 2025
FACULTY BIO
Andrew Armstrong, MD, ScM, FACP
Professor of Medicine, Surgery, Pharmacology and Cancer Biology
Duke University
Tanya Dorff, MD
Professor of Medicine
City of Hope
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.
https://www.practicepointcme.com/CMEHome/talking-prostate-cancer-homologous-recombination-repair-gene-mutation-testing-in-metastatic-prostate-cancer-8
This is an accredited continuing education series of three (3) podcasts as downloadable audio files (MP3). These certified AMA/ABS/ANCC podcasts will clarify the rationale and best-practice approaches for HRRm testing to guide therapeutic strategies in metastatic prostate cancer. Clinical case scenarios are used to enhance the learning experience and provide practical considerations to achieve improved outcomes among patients.
Launch Date: May 30, 2024
Release Date: May 30, 2024
Expiration Date: April 30, 2025
FACULTY BIO
Andrew Armstrong, MD, ScM, FACP
Professor of Medicine, Surgery, Pharmacology and Cancer Biology
Duke University
Tanya Dorff, MD
Professor of Medicine
City of Hope
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.
https://www.practicepointcme.com/CMEHome/talking-prostate-cancer-homologous-recombination-repair-gene-mutation-testing-in-metastatic-prostate-cancer-8
This is an accredited continuing education series of three (3) podcasts as downloadable audio files (MP3). These certified AMA/ABS/ANCC/ACPE podcasts summarize the rationale/mechanism of action and clinical evidence on approved and emerging bispecific antibody therapy in RRMM and aid participants in using these agents safely by using clinical vignettes. The activity also provides guidance on early recognition of key adverse events and strategies to manage them, to ultimately improve outcomes for patients with RRMM.
Launch Date: May 2, 2024
Release Date: May 2, 2024
Expiration Date: April 30, 2025
FACULTY BIO
Jesús G. Berdeja, MD
Director of Multiple Myeloma Research
The Greco-Hainsworth Tennessee Oncology Centers for Research
Joseph Mikhael, MD, MEd, FRCPC, FACP
Professor, Applied Cancer Research and Drug Discovery, Translational Genomics Research Institute (TGen), City of Hope Cancer Center
Chief Medical Officer, International Myeloma Foundation
Consultant Hematologist and Director, Myeloma Research, Phase 1 Program, HonorHealth Research Institute
Adjunct Professor, College of Health Solutions, Arizona State University
Saad Usmani, MD
Chief, Myeloma Service
Memorial Sloan Kettering Cancer Center
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.
https://www.practicepointcme.com/CMEHome/conversations-in-relapsedrefractory-multiple-myeloma-strategies-to-effectively-introduce-optimize-and-sequence-bispecific-antibody-therapy-8
This is an accredited continuing education series of three (3) podcasts as downloadable audio files (MP3). These certified AMA/ABS/ANCC/ACPE podcasts summarize the rationale/mechanism of action and clinical evidence on approved and emerging bispecific antibody therapy in RRMM and aid participants in using these agents safely by using clinical vignettes. The activity also provides guidance on early recognition of key adverse events and strategies to manage them, to ultimately improve outcomes for patients with RRMM.
Launch Date: May 2, 2024
Release Date: May 2, 2024
Expiration Date: April 30, 2025
FACULTY BIO
Jesús G. Berdeja, MD
Director of Multiple Myeloma Research
The Greco-Hainsworth Tennessee Oncology Centers for Research
Joseph Mikhael, MD, MEd, FRCPC, FACP
Professor, Applied Cancer Research and Drug Discovery, Translational Genomics Research Institute (TGen), City of Hope Cancer Center
Chief Medical Officer, International Myeloma Foundation
Consultant Hematologist and Director, Myeloma Research, Phase 1 Program, HonorHealth Research Institute
Adjunct Professor, College of Health Solutions, Arizona State University
Saad Usmani, MD
Chief, Myeloma Service
Memorial Sloan Kettering Cancer Center
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.
https://www.practicepointcme.com/CMEHome/conversations-in-relapsedrefractory-multiple-myeloma-strategies-to-effectively-introduce-optimize-and-sequence-bispecific-antibody-therapy-8
This is an accredited continuing education series of three (3) podcasts as downloadable audio files (MP3). These certified AMA/ABS/ANCC/ACPE podcasts summarize the rationale/mechanism of action and clinical evidence on approved and emerging bispecific antibody therapy in RRMM and aid participants in using these agents safely by using clinical vignettes. The activity also provides guidance on early recognition of key adverse events and strategies to manage them, to ultimately improve outcomes for patients with RRMM.
Launch Date: May 2, 2024
Release Date: May 2, 2024
Expiration Date: April 30, 2025
FACULTY BIO
Jesús G. Berdeja, MD
Director of Multiple Myeloma Research
The Greco-Hainsworth Tennessee Oncology Centers for Research
Joseph Mikhael, MD, MEd, FRCPC, FACP
Professor, Applied Cancer Research and Drug Discovery, Translational Genomics Research Institute (TGen), City of Hope Cancer Center
Chief Medical Officer, International Myeloma Foundation
Consultant Hematologist and Director, Myeloma Research, Phase 1 Program, HonorHealth Research Institute
Adjunct Professor, College of Health Solutions, Arizona State University
Saad Usmani, MD
Chief, Myeloma Service
Memorial Sloan Kettering Cancer Center
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.
https://www.practicepointcme.com/CMEHome/conversations-in-relapsedrefractory-multiple-myeloma-strategies-to-effectively-introduce-optimize-and-sequence-bispecific-antibody-therapy-8
This is an accredited continuing education series of one (1) podcast as a downloadable audio file (MP3). This certified AMA/ABS/ANCC/ACPE podcast will spotlight latest advances in the treatment of HF featuring a leading expert reporting from the 2024 ACC Conference.
Launch Date: April 11, 2024
Release Date: April 11, 2024
Expiration Date: March 31, 2025
FACULTY BIO
Peter P. Toth, MD, PhD, FCCP, FESC, FAHA, FACC
Director of Preventive Cardiology
CGH Medical Center
Professor of Clinical Family and Community Medicine
University of Illinois School of Medicine
Adjunct Professor of Medicine
Division of Cardiology
Johns Hopkins University School of Medicine
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.
https://www.practicepointcme.com/CMEHome/acc-conference-coverage-clinical-clips-in-heart-failure-1
These educational podcasts will spotlight the latest advances in the treatment and prevention of HIV and related comorbidities with a series of "what you need to know" videos from data presented at CROI 2024.
Launch Date: March 12, 2024
Release Date: March 12, 2024
Expiration Date: February 28, 2025
ACTIVITY DESCRIPTION
In this podcast, Dr. Hodder will present highlights from the 2024 Conference on Retroviruses and Opportunistic Infections (CROI) in Denver, Colorado.
FACULTY BIO
Dr. Sally Hodder is a Professor of Medicine at West Virginia University and the Associate Vice President of Clinical and Translational Research at West Virginia University Health.
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.
https://www.practicepointcme.com/CMEHome/clinical-clips174-spotlighting-hot-topics-in-hiv-independent-coverage-from-the-2024-conference-on-retroviruses-and-opportunistic-infections-1
These educational podcasts will spotlight the latest advances in the treatment and prevention of HIV and related comorbidities with a series of "what you need to know" videos from data presented at CROI 2024.
Launch Date: March 12, 2024
Release Date: March 12, 2024
Expiration Date: February 28, 2025
ACTIVITY DESCRIPTION
In this podcast, Dr. Hodder will present highlights from the 2024 Conference on Retroviruses and Opportunistic Infections (CROI) in Denver, Colorado.
FACULTY BIO
Dr. Sally Hodder is a Professor of Medicine at West Virginia University and the Associate Vice President of Clinical and Translational Research at West Virginia University Health.
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.
https://www.practicepointcme.com/CMEHome/clinical-clips174-spotlighting-hot-topics-in-hiv-independent-coverage-from-the-2024-conference-on-retroviruses-and-opportunistic-infections-1
These educational podcasts will spotlight the latest advances in the treatment and prevention of HIV and related comorbidities with a series of "what you need to know" videos from data presented at CROI 2024.
Launch Date: March 12, 2024
Release Date: March 12, 2024
Expiration Date: February 28, 2025
ACTIVITY DESCRIPTION
In this podcast, Dr. Hodder will present highlights from the 2024 Conference on Retroviruses and Opportunistic Infections (CROI) in Denver, Colorado.
FACULTY BIO
Dr. Sally Hodder is a Professor of Medicine at West Virginia University and the Associate Vice President of Clinical and Translational Research at West Virginia University Health.
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.
https://www.practicepointcme.com/CMEHome/clinical-clips174-spotlighting-hot-topics-in-hiv-independent-coverage-from-the-2024-conference-on-retroviruses-and-opportunistic-infections-1
These educational podcasts will spotlight the latest advances in the treatment and prevention of HIV and related comorbidities with a series of "what you need to know" videos from data presented at CROI 2024.
Launch Date: March 12, 2024
Release Date: March 12, 2024
Expiration Date: February 28, 2025
ACTIVITY DESCRIPTION
In this podcast, Dr. Hodder will present highlights from the 2024 Conference on Retroviruses and Opportunistic Infections (CROI) in Denver, Colorado.
FACULTY BIO
Dr. Sally Hodder is a Professor of Medicine at West Virginia University and the Associate Vice President of Clinical and Translational Research at West Virginia University Health.
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.
https://www.practicepointcme.com/CMEHome/clinical-clips174-spotlighting-hot-topics-in-hiv-independent-coverage-from-the-2024-conference-on-retroviruses-and-opportunistic-infections-1
Dyslipidemia is a well-known risk factor for the development of cardiovascular disease, a leading cause of morbidity and mortality. Treatment of dyslipidemia represents one of the most crucial strategies to reduce risk of atherosclerotic cardiovascular (CV) disease (ASCVD). In this podcast series, Dr. Deepak Bhatt and Dr. R. Scott Wright discuss recent clinical trial evidence for CV risk reduction with cholesterol-lowering therapies, with a focus on CV outcomes trials with current and emerging therapies that target proprotein convertase subtilisin/kexin type 9 (PCSK9).
Launch Date: February 16, 2024
Release Date: January 29, 2024
Expiration Date: January 31, 2025
FACULTY
R. Scott Wright, MD, FACC, FESC, FAHA
Professor of Medicine
Consultant in Cardiology
Mayo Clinic
Deepak L. Bhatt, MD, MPH, FACC, FAHA, FESC, MSCAI
Director
Mount Sinai Fuster Heart Hospital
Dr. Valentin Fuster Professor of Cardiovascular Medicine
Icahn School of Medicine at Mount Sinai
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.
https://www.practicepointcme.com/CMEHome/talking-cardiovascular-disease-prevention-emerging-strategies-to-address-management-challenges-in-dyslipidemia-1
Dyslipidemia is a well-known risk factor for the development of cardiovascular disease, a leading cause of morbidity and mortality. Treatment of dyslipidemia represents one of the most crucial strategies to reduce risk of atherosclerotic cardiovascular (CV) disease (ASCVD). In this podcast series, Dr. Deepak Bhatt and Dr. R. Scott Wright discuss recent clinical trial evidence for CV risk reduction with cholesterol-lowering therapies, with a focus on CV outcomes trials with current and emerging therapies that target proprotein convertase subtilisin/kexin type 9 (PCSK9).
Launch Date: February 16, 2024
Release Date: January 29, 2024
Expiration Date: January 31, 2025
FACULTY
R. Scott Wright, MD, FACC, FESC, FAHA
Professor of Medicine
Consultant in Cardiology
Mayo Clinic
Deepak L. Bhatt, MD, MPH, FACC, FAHA, FESC, MSCAI
Director
Mount Sinai Fuster Heart Hospital
Dr. Valentin Fuster Professor of Cardiovascular Medicine
Icahn School of Medicine at Mount Sinai
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.
https://www.practicepointcme.com/CMEHome/talking-cardiovascular-disease-prevention-emerging-strategies-to-address-management-challenges-in-dyslipidemia-1
Dyslipidemia is a well-known risk factor for the development of cardiovascular disease, a leading cause of morbidity and mortality. Treatment of dyslipidemia represents one of the most crucial strategies to reduce risk of atherosclerotic cardiovascular (CV) disease (ASCVD). In this podcast series, Dr. Deepak Bhatt and Dr. R. Scott Wright discuss recent clinical trial evidence for CV risk reduction with cholesterol-lowering therapies, with a focus on CV outcomes trials with current and emerging therapies that target proprotein convertase subtilisin/kexin type 9 (PCSK9).
Launch Date: February 16, 2024
Release Date: January 29, 2024
Expiration Date: January 31, 2025
FACULTY
R. Scott Wright, MD, FACC, FESC, FAHA
Professor of Medicine
Consultant in Cardiology
Mayo Clinic
Deepak L. Bhatt, MD, MPH, FACC, FAHA, FESC, MSCAI
Director
Mount Sinai Fuster Heart Hospital
Dr. Valentin Fuster Professor of Cardiovascular Medicine
Icahn School of Medicine at Mount Sinai
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.
https://www.practicepointcme.com/CMEHome/talking-cardiovascular-disease-prevention-emerging-strategies-to-address-management-challenges-in-dyslipidemia-1
This is an accredited continuing education series of three (3) podcasts as downloadable audio files (MP3). During this podcast series, Gilles Salles, MD, and Matthew Lunning, MD, identify and integrate crucial advances in follicular lymphoma presented at the 2023 American Society of Hematology (ASH) annual conference.
Launch Date: February 1, 2024
Release Date: February 1, 2024
Expiration Date: January 31, 2025
FACULTY BIOS
Gilles Salles, MD
Chief, Lymphoma Service
Memorial Sloan Kettering Cancer Center
Matthew Lunning, DO
Associate Professor of Hematology/Oncology
University of Nebraska Medical Center
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.
https://www.practicepointcme.com/CMEHome/conversations-in-hematologyoncology-incorporating-key-updates-in-the-treatment-of-follicular-lymphoma-a-discussion-following-ash-2023-on-assimilating-practice-changing-breakthroughs-14
This is an accredited continuing education series of three (3) podcasts as downloadable audio files (MP3). During this podcast series, Gilles Salles, MD, and Matthew Lunning, MD, identify and integrate crucial advances in follicular lymphoma presented at the 2023 American Society of Hematology (ASH) annual conference.
Launch Date: February 1, 2024
Release Date: February 1, 2024
Expiration Date: January 31, 2025
FACULTY BIOS
Gilles Salles, MD
Chief, Lymphoma Service
Memorial Sloan Kettering Cancer Center
Matthew Lunning, DO
Associate Professor of Hematology/Oncology
University of Nebraska Medical Center
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.
https://www.practicepointcme.com/CMEHome/conversations-in-hematologyoncology-incorporating-key-updates-in-the-treatment-of-follicular-lymphoma-a-discussion-following-ash-2023-on-assimilating-practice-changing-breakthroughs-14
This is an accredited continuing education series of three (3) podcasts as downloadable audio files (MP3). During this podcast series, Gilles Salles, MD, and Matthew Lunning, MD, identify and integrate crucial advances in follicular lymphoma presented at the 2023 American Society of Hematology (ASH) annual conference.
Launch Date: February 1, 2024
Release Date: February 1, 2024
Expiration Date: January 31, 2025
FACULTY BIOS
Gilles Salles, MD
Chief, Lymphoma Service
Memorial Sloan Kettering Cancer Center
Matthew Lunning, DO
Associate Professor of Hematology/Oncology
University of Nebraska Medical Center
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.
https://www.practicepointcme.com/CMEHome/conversations-in-hematologyoncology-incorporating-key-updates-in-the-treatment-of-follicular-lymphoma-a-discussion-following-ash-2023-on-assimilating-practice-changing-breakthroughs-14
This Conversations in MF podcast will discuss the most clinically relevant data and emerging strategies into practice to improve outcomes for patients with MF presented from the 2023 international meetings of the American Society of Clinical Oncology (ASCO), European Hematology Association (EHA) and Society of Hematologic Oncology (SOHO).
Launch Date: January 29, 2024
Release Date: January 29, 2024
Expiration Date: December 30, 2024
FACULTY BIOS
Prithviraj Bose, MD
Professor, Department of Leukemia, Division of Cancer Medicine
University of Texas
MD Anderson Cancer Center
John Mascarenhas, MD
Professor of Medicine
Icahn School of Medicine at Mount Sinai
Director, Center of Excellence in Blood Cancers and Myeloid Disorders
Ruben Mesa, MD
Executive Director
Atrium Health Wake Forest Baptist Comprehensive Cancer Center
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.
https://www.practicepointcme.com/CMEHome/conference-briefs-highlighting-myelofibrosis-clinical-data-from-key-conferences-17
This Conversations in MF podcast will discuss the most clinically relevant data and emerging strategies into practice to improve outcomes for patients with MF presented from the 2023 international meetings of the American Society of Clinical Oncology (ASCO), European Hematology Association (EHA) and Society of Hematologic Oncology (SOHO).
Launch Date: January 29, 2024
Release Date: January 29, 2024
Expiration Date: December 30, 2024
FACULTY BIOS
Prithviraj Bose, MD
Professor, Department of Leukemia, Division of Cancer Medicine
University of Texas
MD Anderson Cancer Center
John Mascarenhas, MD
Professor of Medicine
Icahn School of Medicine at Mount Sinai
Director, Center of Excellence in Blood Cancers and Myeloid Disorders
Ruben Mesa, MD
Executive Director
Atrium Health Wake Forest Baptist Comprehensive Cancer Center
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.
https://www.practicepointcme.com/CMEHome/conference-briefs-highlighting-myelofibrosis-clinical-data-from-key-conferences-17
This Conversations in MF podcast will discuss the most clinically relevant data and emerging strategies into practice to improve outcomes for patients with MF presented from the 2023 international meetings of the American Society of Clinical Oncology (ASCO), European Hematology Association (EHA) and Society of Hematologic Oncology (SOHO).
Launch Date: January 29, 2024
Release Date: January 29, 2024
Expiration Date: December 30, 2024
FACULTY BIOS
Prithviraj Bose, MD
Professor, Department of Leukemia, Division of Cancer Medicine
University of Texas
MD Anderson Cancer Center
John Mascarenhas, MD
Professor of Medicine
Icahn School of Medicine at Mount Sinai
Director, Center of Excellence in Blood Cancers and Myeloid Disorders
Ruben Mesa, MD
Executive Director
Atrium Health Wake Forest Baptist Comprehensive Cancer Center
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.
https://www.practicepointcme.com/CMEHome/conference-briefs-highlighting-myelofibrosis-clinical-data-from-key-conferences-17
This podcast series, lead by expert faculty, inform and guide the safety and efficacy of TROP2-directed ADCs in different settings of NSCLC treatment that was reported at key conferences such as the World Conference on Lung Cancer (WCLC 2023) and European Society of Medical Oncology (ESMO 2023) annual conference. The expert faculty will also discuss insights into using agents upon availability to enable improved outcomes among distinct subsets of patients.
Launch Date: December 29, 2023
Release Date: December 29, 2023
Expiration Date: November 30, 2024
FACULTY BIOS
Benjamin Levy, MD
Associate Professor of Oncology
Johns Hopkins Medicine
Aaron Lisberg, MD
Assistant Professor of Clinical Medicine
University of California, Los Angeles
Alexander Spira, MD, PhD, FACP
Co-Director
Virginia Cancer Specialists Research Institute
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.
https://www.practicepointcme.com/CMEHome/conversations-in-advanced-nsclc-rationale-and-utility-of-trop2-antibody-drug-conjugates-based-on-updates-from-wclc-and-esmo-1
This podcast series, lead by expert faculty, inform and guide the safety and efficacy of TROP2-directed ADCs in different settings of NSCLC treatment that was reported at key conferences such as the World Conference on Lung Cancer (WCLC 2023) and European Society of Medical Oncology (ESMO 2023) annual conference. The expert faculty will also discuss insights into using agents upon availability to enable improved outcomes among distinct subsets of patients.
Launch Date: December 29, 2023
Release Date: December 29, 2023
Expiration Date: November 30, 2024
FACULTY BIOS
Benjamin Levy, MD
Associate Professor of Oncology
Johns Hopkins Medicine
Aaron Lisberg, MD
Assistant Professor of Clinical Medicine
University of California, Los Angeles
Alexander Spira, MD, PhD, FACP
Co-Director
Virginia Cancer Specialists Research Institute
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.
https://www.practicepointcme.com/CMEHome/conversations-in-advanced-nsclc-rationale-and-utility-of-trop2-antibody-drug-conjugates-based-on-updates-from-wclc-and-esmo-1
This podcast series, lead by expert faculty, inform and guide the safety and efficacy of TROP2-directed ADCs in different settings of NSCLC treatment that was reported at key conferences such as the World Conference on Lung Cancer (WCLC 2023) and European Society of Medical Oncology (ESMO 2023) annual conference. The expert faculty will also discuss insights into using agents upon availability to enable improved outcomes among distinct subsets of patients.
Launch Date: December 29, 2023
Release Date: December 29, 2023
Expiration Date: November 30, 2024
FACULTY BIOS
Benjamin Levy, MD
Associate Professor of Oncology
Johns Hopkins Medicine
Aaron Lisberg, MD
Assistant Professor of Clinical Medicine
University of California, Los Angeles
Alexander Spira, MD, PhD, FACP
Co-Director
Virginia Cancer Specialists Research Institute
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.
https://www.practicepointcme.com/CMEHome/conversations-in-advanced-nsclc-rationale-and-utility-of-trop2-antibody-drug-conjugates-based-on-updates-from-wclc-and-esmo-1
This is an accredited continuing education series of four (4) podcasts as downloadable audio files (MP3). In these dynamic and interactive podcast sessions, Dr. James Bussel and Dr. Cindy Neunert discuss emerging evidence for management strategies for ITP, including utilization of patient reported outcomes and shared decision making to improve outcomes. Two case presentations will be discussed to help clinicians select the most appropriate treatment as well as incorporate patient reported outcomes and shared decision making into their routine clinical practice.
Launch Date: December 28, 2023
Release Date: December 28, 2023
Expiration Date: November 30, 2024
FACULTY BIOS
James Bussel, MD
Professor Emeritus
Pediatric Hematology-Oncology
Weill Cornell Medicine New York
New York, NY
Cindy Neunert, MD
Division of Pediatric Hematology
Oncology, and Stem Cell Transplantation
Columbia University Irving Medical Center
New York, NY
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.
https://www.practicepointcme.com/CMEHome/expert-insights-on-itp-how-do-emerging-treatment-strategies-have-the-potential-to-transform-patient-outcomes-39
This is an accredited continuing education series of four (4) podcasts as downloadable audio files (MP3). In these dynamic and interactive podcast sessions, Dr. James Bussel and Dr. Cindy Neunert discuss emerging evidence for management strategies for ITP, including utilization of patient reported outcomes and shared decision making to improve outcomes. Two case presentations will be discussed to help clinicians select the most appropriate treatment as well as incorporate patient reported outcomes and shared decision making into their routine clinical practice.
Launch Date: December 28, 2023
Release Date: December 28, 2023
Expiration Date: November 30, 2024
FACULTY BIOS
James Bussel, MD
Professor Emeritus
Pediatric Hematology-Oncology
Weill Cornell Medicine New York
New York, NY
Cindy Neunert, MD
Division of Pediatric Hematology
Oncology, and Stem Cell Transplantation
Columbia University Irving Medical Center
New York, NY
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.
https://www.practicepointcme.com/CMEHome/expert-insights-on-itp-how-do-emerging-treatment-strategies-have-the-potential-to-transform-patient-outcomes-39
This is an accredited continuing education series of four (4) podcasts as downloadable audio files (MP3). In these dynamic and interactive podcast sessions, Dr. James Bussel and Dr. Cindy Neunert discuss emerging evidence for management strategies for ITP, including utilization of patient reported outcomes and shared decision making to improve outcomes. Two case presentations will be discussed to help clinicians select the most appropriate treatment as well as incorporate patient reported outcomes and shared decision making into their routine clinical practice.
Launch Date: December 28, 2023
Release Date: December 28, 2023
Expiration Date: November 30, 2028
FACULTY BIOS
James Bussel, MD
Professor Emeritus
Pediatric Hematology-Oncology
Weill Cornell Medicine New York
New York, NY
Cindy Neunert, MD
Division of Pediatric Hematology
Oncology, and Stem Cell Transplantation
Columbia University Irving Medical Center
New York, NY
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.
https://www.practicepointcme.com/CMEHome/expert-insights-on-itp-how-do-emerging-treatment-strategies-have-the-potential-to-transform-patient-outcomes-39
This is an accredited continuing education series of four (4) podcasts as downloadable audio files (MP3). In these dynamic and interactive podcast sessions, Dr. James Bussel and Dr. Cindy Neunert discuss emerging evidence for management strategies for ITP, including utilization of patient reported outcomes and shared decision making to improve outcomes. Two case presentations will be discussed to help clinicians select the most appropriate treatment as well as incorporate patient reported outcomes and shared decision making into their routine clinical practice.
Launch Date: December 28, 2023
Release Date: December 28, 2023
Expiration Date: November 30, 2024
FACULTY BIOS
James Bussel, MD
Professor Emeritus
Pediatric Hematology-Oncology
Weill Cornell Medicine New York
New York, NY
Cindy Neunert, MD
Division of Pediatric Hematology
Oncology, and Stem Cell Transplantation
Columbia University Irving Medical Center
New York, NY
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.
https://www.practicepointcme.com/CMEHome/expert-insights-on-itp-how-do-emerging-treatment-strategies-have-the-potential-to-transform-patient-outcomes-39
Novel therapies targeting the immune system and their combinations are gaining ground in AML. This podcast series, led by expert faculty, will clarify the potential and utility of innovative therapies that harness the immune system and will provide guidance on their applicability into clinical practice, especially for elderly/unfit patients with AML.
Launch Date: December 27, 2023
Release Date: December 27, 2023
Expiration Date: November 30, 2024
FACULTY BIOS
Tapan Kadia, MD
MD Anderson Cancer Institute
University of Texas
Daniel Pollyea, MD
Professor of Medicine
University of Colorado School of Medicine
Department of Hematology
Eunice Wang, MD
Professor of Oncology
Chief, Leukemia/Benign Hematology Service
Department of Medicine
Medical Director, Chemo/Infusion Clinics
Rosewell Park Comprehensive Cancer Center
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.
https://www.practicepointcme.com/CMEHome/conversations-in-acute-myeloid-leukemia-novel-therapies-targeting-the-immune-system-for-elderlyunfit-patients-1
Novel therapies targeting the immune system and their combinations are gaining ground in AML. This podcast series, led by expert faculty, will clarify the potential and utility of innovative therapies that harness the immune system and will provide guidance on their applicability into clinical practice, especially for elderly/unfit patients with AML.
Launch Date: December 27, 2023
Release Date: December 27, 2023
Expiration Date: November 30, 2024
FACULTY BIOS
Tapan Kadia, MD
MD Anderson Cancer Institute
University of Texas
Daniel Pollyea, MD
Professor of Medicine
University of Colorado School of Medicine
Department of Hematology
Eunice Wang, MD
Professor of Oncology
Chief, Leukemia/Benign Hematology Service
Department of Medicine
Medical Director, Chemo/Infusion Clinics
Rosewell Park Comprehensive Cancer Center
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.
https://www.practicepointcme.com/CMEHome/conversations-in-acute-myeloid-leukemia-novel-therapies-targeting-the-immune-system-for-elderlyunfit-patients-1
Novel therapies targeting the immune system and their combinations are gaining ground in AML. This podcast series, led by expert faculty, will clarify the potential and utility of innovative therapies that harness the immune system and will provide guidance on their applicability into clinical practice, especially for elderly/unfit patients with AML.
Launch Date: December 27, 2023
Release Date: December 27, 2023
Expiration Date: November 30, 2024
FACULTY BIOS
Tapan Kadia, MD
MD Anderson Cancer Institute
University of Texas
Daniel Pollyea, MD
Professor of Medicine
University of Colorado School of Medicine
Department of Hematology
Eunice Wang, MD
Professor of Oncology
Chief, Leukemia/Benign Hematology Service
Department of Medicine
Medical Director, Chemo/Infusion Clinics
Rosewell Park Comprehensive Cancer Center
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.
https://www.practicepointcme.com/CMEHome/conversations-in-acute-myeloid-leukemia-novel-therapies-targeting-the-immune-system-for-elderlyunfit-patients-1
This is an accredited continuing education series of two (2) podcasts as downloadable audio files (MP3). In this podcast series, Dr. Scott Canna and Dr. Alexei Grom discuss diverse mechanisms and clinical presentations in patients with suspected MAS, approaches for the timely diagnosis of MAS, and considerations for appropriate treatment and management strategies.
Launch Date: December 21, 2023
Release Date: December 21, 2023
Expiration Date: November 30, 2024
FACULTY BIOS
Scott Canna, MDAssistant Professor of Pediatrics
University of Pennsylvania Perelman School of Medicine
Attending Physician, Rheumatology and Immune Dysregulation
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania
Alexei Grom, MDProfessor of Pediatrics
Research Director
Division of Rheumatology
Cincinnati Children’s Hospital Medical Center
Cincinnati, Ohio
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.
https://www.practicepointcme.com/CMEHome/expert-insights-on-mas-sjiaaosd-and-macrophage-activation-syndrome-an-interactive-case-based-discussion-37
This is an accredited continuing education series of two (2) podcasts as downloadable audio files (MP3). In this podcast series, Dr. Scott Canna and Dr. Alexei Grom discuss diverse mechanisms and clinical presentations in patients with suspected MAS, approaches for the timely diagnosis of MAS, and considerations for appropriate treatment and management strategies.
Launch Date: December 21, 2023
Release Date: December 21, 2023
Expiration Date: November 30, 2024
FACULTY BIOS
Scott Canna, MDAssistant Professor of Pediatrics
University of Pennsylvania Perelman School of Medicine
Attending Physician, Rheumatology and Immune Dysregulation
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania
Alexei Grom, MDProfessor of Pediatrics
Research Director
Division of Rheumatology
Cincinnati Children’s Hospital Medical Center
Cincinnati, Ohio
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.
https://www.practicepointcme.com/CMEHome/expert-insights-on-mas-sjiaaosd-and-macrophage-activation-syndrome-an-interactive-case-based-discussion-37
This is an accredited continuing education series of one (1) podcast as a downloadable audio file (MP3). This certified AMA/ABS/ANCC podcast will spotlight latest advances in the treatment of ITP featuring a leading expert reporting from the 2023 ASH Conference.
Launch Date: December 19, 2023
Release Date: December 19, 2023
Expiration Date: November 30, 2024
FACULTY BIO
Hanny Al-Samkari, MD
The Peggy S. Blitz Endowed Chair in Hematology/Oncology
Associate Professor of Medicine,
Harvard Medical School
Co-Director, Hereditary Hemorrhagic Telangiectasia Center of Excellence
Massachusetts General Hospital, Boston, MA
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.
https://www.practicepointcme.com/CMEHome/clinical-clips174-spotlighting-hot-topics-in-itp
This is an accredited continuing education series of three (3) podcasts as downloadable audio files (MP3). During this podcast series, Drs Philip Mease and April Armstrong will inform and guide on keeping up with recent progress and safely integrating it into clinical treatment paradigms of PsA.
Launch Date: December 15, 2023
Release Date: December 15, 2023
Expiration Date: November 30, 2024
FACULTY BIOS
Philip Mease, MD, MACR
Director, Rheumatology Research
Swedish Medical Center/ Providence St. Joseph Health
Clinical Professor
University of Washington School of Medicine
April Armstrong, MD, MPH
Professor and Chief
Division of Dermatology
University of California Los Angeles
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.
https://www.practicepointcme.com/CMEHome/expert-insights-on-psa-how-do-personalized-treatment-options-transform-patient-outcomes-47
This is an accredited continuing education series of three (3) podcasts as downloadable audio files (MP3). During this podcast series, Drs Philip Mease and April Armstrong will inform and guide on keeping up with recent progress and safely integrating it into clinical treatment paradigms of PsA.
Launch Date: December 15, 2023
Release Date: December 15, 2023
Expiration Date: November 30, 2024
FACULTY BIOS
Philip Mease, MD, MACR
Director, Rheumatology Research
Swedish Medical Center/ Providence St. Joseph Health
Clinical Professor
University of Washington School of Medicine
April Armstrong, MD, MPH
Professor and Chief
Division of Dermatology
University of California Los Angeles
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.
https://www.practicepointcme.com/CMEHome/expert-insights-on-psa-how-do-personalized-treatment-options-transform-patient-outcomes-47
This is an accredited continuing education series of three (3) podcasts as downloadable audio files (MP3). During this podcast series, Drs Philip Mease and April Armstrong will inform and guide on keeping up with recent progress and safely integrating it into clinical treatment paradigms of PsA.
Launch Date: December 15, 2023
Release Date: December 15, 2023
Expiration Date: November 30, 2024
FACULTY BIOS
Philip Mease, MD, MACR
Director, Rheumatology Research
Swedish Medical Center/ Providence St. Joseph Health
Clinical Professor
University of Washington School of Medicine
April Armstrong, MD, MPH
Professor and Chief
Division of Dermatology
University of California Los Angeles
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.
https://www.practicepointcme.com/CMEHome/expert-insights-on-psa-how-do-personalized-treatment-options-transform-patient-outcomes-47
This is an accredited continuing education series of four (4) podcasts as downloadable audio files (MP3). During this podcast series, Guy Young, MD, and Angela Weyand, MD, will inform and guide on keeping up with recent progress and safely integrating it into clinical treatment paradigms of severe hemophilia A. Topics covered include recent practice-changing updates in replacement and non-replacement therapies in hemophilia A, case presentations to aid in selecting the most appropriate treatment for diverse patients with severe hemophilia A, novel non-replacement therapy and gene therapy as well as case scenarios to examine the utility of gene therapy.
Launch Date: November 21, 2023
Release Date: November 21, 2023
Expiration Date: October 31, 2024
FACULTY BIOS
Angela Weyand, MD
Associate Professor of Medicine
University of Michigan Medical School
Guy Young, MD
Professor of Pediatrics
University of Southern California Keck School of Medicine
Director, Hemostasis and Thrombosis Center
Children’s Hospital Los Angeles
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.
https://www.practicepointcme.com/CMEHome/practice-changing-updates-the-evolving-treatment-landscape-in-hemophilia-a-44
This is an accredited continuing education series of four (4) podcasts as downloadable audio files (MP3). During this podcast series, Guy Young, MD, and Angela Weyand, MD, will inform and guide on keeping up with recent progress and safely integrating it into clinical treatment paradigms of severe hemophilia A. Topics covered include recent practice-changing updates in replacement and non-replacement therapies in hemophilia A, case presentations to aid in selecting the most appropriate treatment for diverse patients with severe hemophilia A, novel non-replacement therapy and gene therapy as well as case scenarios to examine the utility of gene therapy.
Launch Date: November 21, 2023
Release Date: November 21, 2023
Expiration Date: October 31, 2024
FACULTY BIOS
Angela Weyand, MD
Associate Professor of Medicine
University of Michigan Medical School
Guy Young, MD
Professor of Pediatrics
University of Southern California Keck School of Medicine
Director, Hemostasis and Thrombosis Center
Children’s Hospital Los Angeles
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.
https://www.practicepointcme.com/CMEHome/practice-changing-updates-the-evolving-treatment-landscape-in-hemophilia-a-44
This is an accredited continuing education series of four (4) podcasts as downloadable audio files (MP3). During this podcast series, Guy Young, MD, and Angela Weyand, MD, will inform and guide on keeping up with recent progress and safely integrating it into clinical treatment paradigms of severe hemophilia A. Topics covered include recent practice-changing updates in replacement and non-replacement therapies in hemophilia A, case presentations to aid in selecting the most appropriate treatment for diverse patients with severe hemophilia A, novel non-replacement therapy and gene therapy as well as case scenarios to examine the utility of gene therapy.
Launch Date: November 21, 2023
Release Date: November 21, 2023
Expiration Date: October 31, 2024
FACULTY BIOS
Angela Weyand, MD
Associate Professor of Medicine
University of Michigan Medical School
Guy Young, MD
Professor of Pediatrics
University of Southern California Keck School of Medicine
Director, Hemostasis and Thrombosis Center
Children’s Hospital Los Angeles
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.
https://www.practicepointcme.com/CMEHome/practice-changing-updates-the-evolving-treatment-landscape-in-hemophilia-a-44
This is an accredited continuing education series of four (4) podcasts as downloadable audio files (MP3). During this podcast series, Guy Young, MD, and Angela Weyand, MD, will inform and guide on keeping up with recent progress and safely integrating it into clinical treatment paradigms of severe hemophilia A. Topics covered include recent practice-changing updates in replacement and non-replacement therapies in hemophilia A, case presentations to aid in selecting the most appropriate treatment for diverse patients with severe hemophilia A, novel non-replacement therapy and gene therapy as well as case scenarios to examine the utility of gene therapy.
Launch Date: November 21, 2023
Release Date: November 21, 2023
Expiration Date: October 31, 2024
FACULTY BIOS
Angela Weyand, MD
Associate Professor of Medicine
University of Michigan Medical School
Guy Young, MD
Professor of Pediatrics
University of Southern California Keck School of Medicine
Director, Hemostasis and Thrombosis Center
Children’s Hospital Los Angeles
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.
https://www.practicepointcme.com/CMEHome/practice-changing-updates-the-evolving-treatment-landscape-in-hemophilia-a-44
This educational podcast will provide learners with the opportunity to enhance clinical decision-making skills about the diagnosis and management of Triple-negative breast cancer (TNBC).
Launch Date: November 9, 2023
Release Date: November 9, 2023
Expiration Date: October 31, 2024
ACTIVITY DESCRIPTION
In this podcast, Drs. William Gradishar, Yuan Yuan and Rita Nanda will review the latest clinical evidence and patient management approaches in TNBC to enhance patient-centered care.
FACULTY BIOS
Dr. William Gradishar is the Chief of Hematology and Oncology in the Department of Medicine at Northwestern University Feinberg School of Medicine in Chicago, Illinois.
Dr. Yuan Yuan is the Director of Breast Cancer Research at Cedar-Sinai Medical Center in Los Angeles, California.
Dr. Rita Nanda is the Associate Professor of Medicine at the University of Chicago Medicine in Chicago, Illinois.
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.
https://www.practicepointcme.com/CMEHome/treatment-progress-in-triple-negative-breast-cancer-improving-disparities-and-outcomes-with-new-approaches-32
This educational podcast will provide learners with the opportunity to enhance clinical decision-making skills about the diagnosis and management of Triple-negative breast cancer (TNBC).
Launch Date: November 9, 2023
Release Date: November 9, 2023
Expiration Date: October 31, 2024
ACTIVITY DESCRIPTION
In this podcast, Drs. William Gradishar, Yuan Yuan and Rita Nanda will review the latest clinical evidence and patient management approaches in TNBC to enhance patient-centered care.
FACULTY BIOS
Dr. William Gradishar is the Chief of Hematology and Oncology in the Department of Medicine at Northwestern University Feinberg School of Medicine in Chicago, Illinois.
Dr. Yuan Yuan is the Director of Breast Cancer Research at Cedar-Sinai Medical Center in Los Angeles, California.
Dr. Rita Nanda is the Associate Professor of Medicine at the University of Chicago Medicine in Chicago, Illinois.
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.
https://www.practicepointcme.com/CMEHome/treatment-progress-in-triple-negative-breast-cancer-improving-disparities-and-outcomes-with-new-approaches-32
This educational podcast will provide learners with the opportunity to enhance clinical decision-making skills about the diagnosis and management of Triple-negative breast cancer (TNBC).
Launch Date: November 9, 2023
Release Date: November 9, 2023
Expiration Date: October 31, 2024
ACTIVITY DESCRIPTION
In this podcast, Drs. William Gradishar, Yuan Yuan and Rita Nanda will review the latest clinical evidence and patient management approaches in TNBC to enhance patient-centered care.
FACULTY BIOS
Dr. William Gradishar is the Chief of Hematology and Oncology in the Department of Medicine at Northwestern University Feinberg School of Medicine in Chicago, Illinois.
Dr. Yuan Yuan is the Director of Breast Cancer Research at Cedar-Sinai Medical Center in Los Angeles, California.
Dr. Rita Nanda is the Associate Professor of Medicine at the University of Chicago Medicine in Chicago, Illinois.
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.
https://www.practicepointcme.com/CMEHome/treatment-progress-in-triple-negative-breast-cancer-improving-disparities-and-outcomes-with-new-approaches-32
INTRODUCTION
This is an accredited continuing education series of two (2) podcasts as downloadable audio files (MP3). Dr. Raj Chovatiya and Dr. David Rosmarin will provide expert interpretation of new data for current and emerging treatment options of vitiligo, along with practical considerations for how new agents can impact patient outcomes. Case presentations will be discussed to help clinicians select the most appropriate treatment as well as address the significant health burdens and complications experienced by many patients during treatment.
Launch Date: November 8, 2023
Release Date: November 8, 2023
Expiration Date: October 31, 2024
FACULTY BIOS
David Rosmarin, MD
Chair Department of Dermatology
Kapens Norrins Scholar
Indiana University School of Medicine
Indianapolis, Indiana
Raj Chovatiya, MD, PhD, MSCI, FAAD
Assistant Professor of Dermatology
Northwestern University Feinberg School of Medicine
Chicago, Illinois
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.
https://www.practicepointcme.com/CMEHome/expert-insights-on-vitiligo-how-do-emerging-treatment-options-have-the-potential-to-transform-patient-outcomes
INTRODUCTION
This is an accredited continuing education series of two (2) podcasts as downloadable audio files (MP3). Dr. Raj Chovatiya and Dr. David Rosmarin will provide expert interpretation of new data for current and emerging treatment options of vitiligo, along with practical considerations for how new agents can impact patient outcomes. Case presentations will be discussed to help clinicians select the most appropriate treatment as well as address the significant health burdens and complications experienced by many patients during treatment.
Launch Date: November 8, 2023
Release Date: November 8, 2023
Expiration Date: October 31, 2024
FACULTY BIOS
David Rosmarin, MD
Chair Department of Dermatology
Kapens Norrins Scholar
Indiana University School of Medicine
Indianapolis, Indiana
Raj Chovatiya, MD, PhD, MSCI, FAAD
Assistant Professor of Dermatology
Northwestern University Feinberg School of Medicine
Chicago, Illinois
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.
https://www.practicepointcme.com/CMEHome/expert-insights-on-vitiligo-how-do-emerging-treatment-options-have-the-potential-to-transform-patient-outcomes
This educational podcast will provide expert commentary spotlighting hot topics in non-small cell lung cancer (NSCLC) harboring EGFR mutations
Launch Date: November 1, 2023
Release Date: November 1, 2023
Expiration Date: October 31, 2024
ACTIVITY DESCRIPTION
In this podcast, Dr. Chaft will present highlights from the 2023 European Society for Medical Oncology (ESMO) Congress in Madrid, Spain.
FACULTY BIO
Dr. Jamie Chaft is an Associate Attending Physician at Memorial Sloan Kettering Cancer Center and an Associate Professor at Weill Cornell Medical College.
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.
https://www.practicepointcme.com/CMEHome/clinical-clips-spotlighting-hot-topics-in-nsclc-harboring-egfr-mutations
This educational podcast will review common patient considerations in the treatment and management of HIV.
Launch Date: October 24, 2023
Release Date: October 24, 2023
Expiration Date: September 30, 2024
ACTIVITY DESCRIPTION
In this podcast, Dr. Short and his patient, a 40-year-old male with HIV and multiple comorbidities discuss issues related to interpretation/disclosure of HIV test results and evolving ART considerations.
FACULTY BIO
Dr. William Short is a Associate Professor of Medicine at Perelman School of Medicine at University of Pennsylvania.
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode. https://www.practicepointcme.com/CMEHome/patient-voices-in-hiv-management-a-ce-podcast-series
This educational podcast will review common patient considerations in the treatment and management of HIV.
Launch Date: October 4, 2023
Release Date: October 4, 2023
Expiration Date: September 30, 2024
ACTIVITY DESCRIPTION
In this podcast, Dr. Gandhi and her patient, an African American heterosexual female with HIV, discuss issues related to stigma, confidentiality, and ART.
FACULTY BIO
Dr. Monica Gandhi is a Professor of Medicine at the University of California, San Francisco.
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode. https://www.practicepointcme.com/CMEHome/patient-voices-in-hiv-management-a-ce-podcast-series
This educational podcast will review common patient considerations in the treatment and management of HIV.
Launch Date: September 12, 2023
Release Date: September 12, 2023
Expiration Date: August 31, 2024
ACTIVITY DESCRIPTION
In this podcast, Dr. Julian Gold and a patient will discuss Stigma, Health and ART.
FACULTY BIO
Dr. Julian Gold is a Senior Staff Specialist at New South Wales Health Department and a Clinical Professor at the University of Sydney.
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode. https://www.practicepointcme.com/CMEHome/patient-voices-in-hiv-management-a-ce-podcast-series
This educational podcast will review common patient considerations in the treatment and management of HIV.
Launch Date: August 22, 2023
Release Date: August 22, 2023
Expiration Date: July 31, 2024
ACTIVITY DESCRIPTION
In this podcast, Dr. David Wohl and a patient will discuss a Long-Term HIV/ART Experience.
FACULTY BIO
David Wohl, MD is a Professor of Medicine at the University of North Carolina at Chapel Hill and the Co-Principal Investigator at the UNC Global Infectious Diseases Clinical Trials Unit.
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode. https://www.practicepointcme.com/CMEHome/patient-voices-in-hiv-management-a-ce-podcast-series
This educational podcast will review common patient considerations in the treatment and management of HIV.
Launch Date: December 13, 2022
Release Date: December 13, 2022
Expiration Date: November 30, 2023
ACTIVITY DESCRIPTION
In this podcast, Dr. Samantha Hill and a patient will discuss management challenges.
FACULTY BIO
Samantha Hill, MD, MPH is the Director of Diversity, Equity, and Inclusion for Graduate Medical Education and Assistant Professor Department of Pediatrics, Division of Adolescent Medicine at University of Alabama at Birmingham.
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode. https://www.practicepointcme.com/CMEHome/patient-perspectives-in-hiv-a-ce-podcast-series-39
This educational podcast will review common patient considerations in the treatment and management of HIV.
Launch Date: September 8, 2022
Release Date: September 1, 2022
Expiration Date: August 31, 2023
ACTIVITY DESCRIPTION
In this podcast, Dr. Richard Elion and a patient will discuss committing to PrEP.
FACULTY BIO
Richard Elion, MD, ABFP is a professor of medicine and George Washington University School of Medicine.
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode. https://www.practicepointcme.com/CMEHome/patient-perspectives-in-hiv-a-ce-podcast-series-39
This educational podcast will review common patient considerations in the treatment and management of HIV.
Launch Date: July 14, 2022
Release Date: June 30, 2022
Expiration Date: May 31, 2023
ACTIVITY DESCRIPTION
In this podcast, Dr. Darcy Wooten and a patient will discuss special considerations on switching ART regimens and long-acting injectable HIV treatment.
FACULTY BIO
Darcy Wooten, MD is an Associate Professor of Medicine at University of California, San Diego.
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode. https://www.practicepointcme.com/CMEHome/patient-perspectives-in-hiv-a-ce-podcast-series-39
INTRODUCTIONThis educational podcast will review common patient considerations for PrEP and barriers to care for HIV prevention.
Launch Date: November 23, 2021
Release Date: November 23, 2021
Expiration Date: October 31, 2022
ACTIVITY DESCRIPTIONIn this podcast, Dr. Latesha Elopre and a cisgender woman whose partner recently tested positive for HIV discuss the perception of risk, side effects of PrEP and family planning concerns.
FACULTY BIODr. Latesha Elopre is an Assistant Professor in the Department of Medicine, Division of Infectious Diseases at the University of Alabama at Birmingham.
This podcast provides accredited continuing education credits. To qualify for credit, please visit https://bit.ly/3oDM1Bl and read all accreditation information at this link prior to listening to this episode.
INTRODUCTION
In this series of podcasts, the content faculty and one of their patients will discuss their patients’ considerations and challenges in managing HIV.
Launch Date: October 25, 2021
Release Date: October 06, 2021
Expiration Date: September 30, 2022
ACTIVITY DESCRIPTION
In this podcast, Dr. Jason Halperin and a patient will discuss the perceived risk of being infected with HIV, starting ART, long term consequences of HIV and U=U.
FACULTY BIO
Jason Halperin, MD, MPH is an Infectious Disease Clinical Lead at CrescentCare and Assistant Professor of Clinical Medicine at Tulane University.
This podcast provides accredited continuing education credits. To qualify for credit, please visit https://bit.ly/3DXphCe and read all accreditation information at this link prior to listening to this episode.
INTRODUCTION
This is an accredited continuing education series of four (4) podcasts as downloadable audio files (MP3). These podcasts will be released quarterly throughout 2021 and will feature patient testimonial along with their physician to discuss today’s patient concerns.
Launch Date: October 14, 2021
ACPE Release Date: October 14, 2021
Expiration Date: September 30, 2022
FACULTY BIO
Anthony Martinez, MD, AAHIVS, FAASLD
Associate Professor of Medicine
Jacobs School of Medicine
University at Buffalo
Medical Director, Hepatology
Erie County Medical Center
Buffalo, NY
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.
https://bit.ly/2QC8Wjq
INTRODUCTION
This is an accredited continuing education series of four (4) podcasts as downloadable audio files (MP3). These podcasts will be released throughout 2021 and feature a patient testimonial along with their physician discussing today’s patient concerns.
Launch Date: September 7, 2021
Release Date: September 6, 2021
Expiration Date: August 31, 2022
FACULTY BIO
Anthony Martinez, MD, AAHIVS, FAASLD
Associate Professor of Medicine
Jacobs School of Medicine
University at Buffalo
Medical Director, Hepatology
Erie County Medical Center
Buffalo, NY
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.
https://bit.ly/2QC8Wjq
INTRODUCTION
This is an accredited continuing education series of four (4) podcasts as downloadable audio files (MP3). These podcasts will be released throughout 2021 and feature a patient testimonial along with their physician discussing today’s patient concerns.
Launch Date: July 13, 2021
Release Date: July 13, 2021
Expiration Date: June 30, 2022
FACULTY BIO
Anthony Martinez, MD, AAHIVS, FAASLD
Associate Professor of Medicine
Jacobs School of Medicine
University at Buffalo
Medical Director, Hepatology
Erie County Medical Center
Buffalo, NY
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.
https://bit.ly/2QC8Wjq
INTRODUCTION
In this series of podcasts, the content faculty and one of their patients will discuss considerations and challenges in the management of and treatment options for HIV.
Launch Date: July 8, 2021
ACPE Release Date: June 25, 2021
Expiration Date: June 30, 2022
ACTIVITY DESCRIPTION
In this podcast, Dr. Babafemi Taiwo and a patient will discuss challenges and management strategies in the setting of multiple comorbidities and multi-drug resistance.
FACULTY BIO
Babafemi Taiwo, MBBS is a Professor of Medicine at Northwestern University Feinberg School of Medicine.
This podcast provides accredited continuing education credits. To qualify for credit, please visit https://bit.ly/3wxpEjp and read all accreditation information at this link prior to listening to this episode.
INTRODUCTION
In this series of podcasts, the content faculty and one of their patients will discuss considerations and challenges in the management of and treatment options for HIV.
Launch Date: June 8, 2021
Release Date: May 25, 2021
Expiration Date: May 31, 2022
ACTIVITY DESCRIPTION
In this podcast, Dr. Monica Gandhi and a patient will discuss special considerations transgender patients may face in the treatment of HIV, the challenges faced by a person with HIV when interacting with their healthcare provider, and concerns and strategies in managing addiction.
FACULTY BIO
Monica Gandhi, MD is a Professor of Medicine at the University of California, San Francisco.
This podcast provides accredited continuing education credits. To qualify for credit, please visit https://bit.ly/2RMYRRn and read all accreditation information at this link prior to listening to this episode.
INTRODUCTION
This educational podcast will focus on the initial hepatitis C diagnosis and the challenges the patient faces when interacting with their healthcare provider.
Launch Date: May 24, 2021
ACPE Release Date: April 26, 2021
Expiration Date: April 30, 2022
ACTIVITY DESCRIPTION
In this CE podcast series, Dr. Anthony Martinez will discuss his patient's life experience with HCV infection, including diagnosis, interactions with healthcare providers, top treatment concerns, and how life changed since being cured. The series will also discuss approaches to improve HCV outcomes based on lessons learned from these patient perspectives.
FACULTY BIO
Anthony Martinez, MD, AAHIVS, FAASLD
Associate Professor of Medicine
Jacobs School of Medicine
University at Buffalo
Medical Director, Hepatology
Erie County Medical Center
Buffalo, NY
This podcast provides accredited continuing education credits. To qualify for credit, please visit https://bit.ly/2QC8Wjq and read all accreditation information at this link prior to listening to this episode.
INTRODUCTIONThis educational podcast will review common patient considerations for PrEP and barriers to care for HIV prevention.
Launch Date: May 21, 2021
Release Date: May 17, 2021
Expiration Date: April 30, 2022
ACTIVITY DESCRIPTIONIn this podcast, Dr. Allison Agwu and a patient with long-term experience on PrEP will discuss common patient considerations and barriers to care such as the perception of risk of HIV infection, preventative approaches, what to consider when starting PrEP, and how they handled challenges.
FACULTY BIOAllison Agwu, MD, ScM is a Professor of Pediatrics at Johns Hopkins University.
This podcast provides accredited continuing education credits. To qualify for credit, please visit https://bit.ly/2SVuGaK and read all accreditation information at this link prior to listening to this episode.